Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment-Reference-Cited by-同舟云学术

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment

Published:2016-10 Issue:4 Volume:65 Page:856-858
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Kozbial Karin,Moser Stephan,Schwarzer Remy,Laferl Hermann,Al-Zoairy Ramona,Stauber Rudolf,Stättermayer Albert F.,Beinhardt Sandra,Graziadei Ivo,Freissmuth Clarissa,Maieron Andreas,Gschwantler Michael,Strasser Michael,Peck-Radosalvjevic Markus,Trauner Michael,Hofer Harald,Ferenci Peter

Publisher

Elsevier BV

Subject

Hepatology

Reference17 articles.

1. Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution;Reig;J Hepatol,2016

2. Buonfiglioli F, Conti F, Andreone P, Crespi C, Foschi FG, Marco Lenzi, et al. Development of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. Late Breaker Abstract, 51. Annual Meeting of EASL, Barcelona, 2016.

3. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients;Park;Hepatology,2012

4. Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN-free therapy for HCV;Toyoda;Hepatology,2016

5. Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population;van der Meer;JAMA,2014

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs;Annals of Hepatology;2024-09

2. Differences in the course of hepatocellular carcinoma depending on the DAA treatment;Prospects in Pharmaceutical Sciences;2024-08-16

3. Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study;Egyptian Journal of Radiology and Nuclear Medicine;2024-05-03

4. Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity;European Journal of Immunology;2024-05-03

5. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study;World Journal of Hepatology;2024-01-27